Literature DB >> 10512092

Do antidepressants have any potential to cause addiction?

P Haddad1.   

Abstract

Addiction/dependence is a syndrome in which the hallmark is a compulsive pattern of drug use. Most authorities do not regard antidepressants as causing addiction but this has been challenged. This debate is explored drawing on case reports and related clinical and pharmacological data. An extensive literature review identified 21 English language case reports of antidepressant addiction (DSM-IV 'substance dependence' criteria) published since 1963. Sixteen involved tranylcypromine or amineptine and may reflect their dopaminergic and stimulant properties. Subject characteristics included male sex (14/21), personality problems (10/21) and prior substance misuse (14/21). Withdrawal or discontinuation symptoms have long been recognized with antidepressants but other features of addiction such as tolerance and compulsive use are exceptionally rare. Common clinical problems are patients taking subtherapeutic dosages and prematurely stopping antidepressants. The pharmacodynamic profiles of most antidepressants and the absence of acute 'desirable' effects make addiction theoretically unlikely. It is concluded that, with the exception of tranylcypromine and amineptine, antidepressants do not have a clinically significant liability to cause addiction. Tranylcypromine and amineptine should be avoided in those with a history of substance misuse. Patients prescribed other antidepressants should be told that they are not addictive.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512092     DOI: 10.1177/026988119901300321

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  10 in total

1.  Uncontrolled self-medication with venlafaxine in a patient with major depressive disorder.

Authors:  Ji-Hye Song; Bum-Hee Yu; Dongsoo Lee; Se Chang Yoon; Hong Jin Jeon
Journal:  Psychiatry Investig       Date:  2010-12-31       Impact factor: 2.505

2.  Estimating the relative reinforcing strength of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine.

Authors:  Zhixia Wang; William L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  2006-10-25       Impact factor: 4.530

3.  Nortriptyline Enhances Morphine-Conditioned Place Preference in Neuropathic Rats: Role of the Central Noradrenergic System.

Authors:  Wenli Mi; Shuxing Wang; Zerong You; Grewo Lim; Michael F McCabe; Hyangin Kim; Lucy Chen; Jianren Mao
Journal:  Anesth Analg       Date:  2017-09       Impact factor: 5.108

4.  Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review.

Authors:  Boadie W Dunlop; Paula G Davis
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 5.  Patient barriers to and enablers of deprescribing: a systematic review.

Authors:  Emily Reeve; Josephine To; Ivanka Hendrix; Sepehr Shakib; Michael S Roberts; Michael D Wiese
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

Review 6.  Antidepressant discontinuation syndromes.

Authors:  P M Haddad
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

7.  Antidepressants, withdrawal, and addiction; where are we now?

Authors:  Sameer Jauhar; Joseph Hayes; Guy M Goodwin; David S Baldwin; Philip J Cowen; David J Nutt
Journal:  J Psychopharmacol       Date:  2019-05-21       Impact factor: 4.562

Review 8.  Abuse and misuse of antidepressants.

Authors:  Elizabeth A Evans; Maria A Sullivan
Journal:  Subst Abuse Rehabil       Date:  2014-08-14

Review 9.  Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network.

Authors:  Thomas Soeiro; Clémence Lacroix; Vincent Pradel; Maryse Lapeyre-Mestre; Joëlle Micallef
Journal:  Front Psychiatry       Date:  2021-05-17       Impact factor: 4.157

10.  Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association.

Authors:  Andreas Vilhelmsson; Tommy Svensson; Anna Meeuwisse; Anders Carlsten
Journal:  BMC Pharmacol Toxicol       Date:  2012-12-23       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.